IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

Clinical trial NCT07138222 · RECRUITING

Trial details

NCT number: NCT07138222
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma (Skin Cancer)

Start date: 2025-09-11
Primary completion: 2026-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.